Celgene Announces Positive Results from RADIANCE, the Second Pivotal Phase III Trial of Oral Ozanimod in Patients with Relapsing Multiple Sclerosis
We take a close look at the fund options.
We take a closer look at India, Taiwan, and Malaysia.
The Bond King's departure had a small impact on CEF performance compared with the onslaught in the commodities market.
Appears to be priced in, for now.
Despite the market's wild ride, most CEFs closed the year with positive share price and NAV returns.
When it comes to expenses, CEFs are quite different than open-end mutual funds.
A look at ownership data can provide a more detailed look at what mutual funds and institutional players are buying and selling.
Plus, Wasatch to launch India fund , and more.